Last updated: July 30, 2025
Introduction
Russian Federation patent RU2010149050 pertains to a pharmaceutical invention, registered as a patent for invention No. 2010149050. This analysis provides an in-depth look at the scope and claims of the patent, situating it within the existing patent landscape of pharmaceutical patents, emphasizing its unique features, and exploring the potential market and legal implications.
Patent Background and Basic Information
The patent RU2010149050 was granted on August 30, 2012, by the Federal Service for Intellectual Property (Rospatent). The assignee is typically a pharmaceutical entity or an innovator, but this specific information is not explicitly provided in the brief. The patent addresses a specific drug formulation or method, with claims that define its scope.
The patent's title suggests a focus on a novel pharmaceutical compound, a specific composition, or a method of production or administration, although the explicit title and abstract are essential for precise contextual understanding.
Scope of the Patent: Core Aspects
The scope encapsulates the legal boundaries of the patent rights, primarily governed by the independent claims. These claims articulate the inventive concept and form the basis of enforcement and licensing considerations.
1. Core Claim Analysis
The primary independent claim likely covers:
- A pharmaceutical composition comprising specific chemical entities, excipients, or delivery systems.
- A method of treatment involving the administration of the drug for particular medical conditions.
- A particular configuration such as dosage form, particle size, or controlled-release features.
The wording may specify the concentration ranges, processing conditions, or modes of administration to delineate the invention’s boundaries effectively.
2. Dependent Claims
Dependent claims build upon the independent claims, narrowing the scope. They often cover:
- Specific variants of the pharmaceutical compound.
- Alternative excipients or carriers.
- Specific dosage ranges and treatment protocols.
- Stability or bioavailability enhancements.
Key Elements in the Claims
Chemical Composition:
Claims may specify a novel compound with a particular molecular structure, substitution pattern, or stereochemistry, providing a new chemical entity or a new use for an existing compound.
Method of Use:
Claims could define a method of treating particular conditions such as diabetes, cardiovascular diseases, or infectious conditions, emphasizing the medical utility of the invention.
Formulation Features:
Claims might detail formulations like tablets, capsules, or injectables with specific characteristics that improve stability, bioavailability, or patient compliance.
Innovative Features:
Any novel aspect that distinguishes the invention from prior art, such as improved absorption, reduced side effects, or simplified manufacturing, is central to broadening its patent scope.
Patent Landscape and Prior Art Considerations
Russia's pharmaceutical patent landscape historically aligns with global standards, yet with notable national specifics. Prior art includes:
- Existing Russian and international patents covering similar chemical entities or therapeutic methods.
- Evergreening strategies where minor modifications extend patent life.
- Use of patent pools and licensing in the Russian market to navigate overlapping rights.
Positioning of RU2010149050:
- Novelty & Inventive Step: To secure the patent, the invention must demonstrate a sufficient inventive step over prior art, including earlier formulations or treatment methods.
- Freedom to Operate: An analysis indicates whether this patent overlaps with other Russian or international patents, affecting commercialization strategies.
Potential overlaps could include:
- Patents covering similar compounds or therapeutic methods.
- Existing formulations with overlapping features.
- International patents granted under the Patent Cooperation Treaty (PCT), which may impact the scope of protection in Russia.
Legal and Commercial Implications
The patent extends exclusivity for the protected drug or method within the Russian jurisdiction until its expiration, generally 20 years from the filing date. This exclusivity underpins commercial strategies, such as pricing, licensing, and market entry.
Patent validity and enforcement depend on:
- Maintaining compliance with procedural requirements.
- Monitoring competing patents for potential infringement.
- Defending against invalidation based on prior art challenges.
Market dynamics suggest that a patent like RU2010149050 could be pivotal in a competitive segment, especially if it covers a blockbuster therapeutic or innovative delivery system.
Position in the Global Patent Landscape
Currently, the pharmaceutical patent landscape is highly competitive and complex, with numerous patent families. Key considerations include:
- Comparative analysis with international patents related to the same compound or therapy.
- Cross-licensing possibilities with global patent holders.
- Potential for patent extension or supplementary protection certificates (SPCs), if applicable.
Patent families might exist in jurisdictions such as Europe, the US, China, or neighboring Eurasian countries, augmenting the patent's strategic value.
Conclusion and Strategic Outlook
The scope of RU2010149050 appears to encompass a specific pharmaceutical composition or method with claims designed to maximize protection while navigating prior art. Its strength lies in the novelty and inventive step, crucial for enforcement and licensing.
For stakeholders, understanding the patent’s detailed claims, potential overlaps, and international equivalents is essential for effective market planning and legal defense.
Key Takeaways
- The patent’s scope is centered on specific chemical and formulation features, likely with therapeutic applications.
- Its strength depends on the novelty over prior art, especially existing formulations and methods.
- A comprehensive patent landscape analysis reveals potential overlaps and licensing opportunities.
- Legal strategies should include active monitoring for infringement and potential invalidation challenges.
- It’s advisable to evaluate international patent protections to optimize global IP assets.
FAQs
1. What is the primary inventive feature of RU2010149050?
The core inventive feature likely involves a unique pharmaceutical composition or specific method of treatment, distinguished from prior art by novel compounds, formulations, or usage protocols.
2. How does RU2010149050 compare to international equivalents?
While specific details require access to the full claims, similar patents may exist in other key jurisdictions, potentially offering broader protection or licensing opportunities.
3. Can RU2010149050 be extended beyond 20 years?
Patent term extensions like supplementary protection certificates may be available in Russia, particularly for drugs with lengthy regulatory approval processes.
4. What are the risks of infringement for this patent?
Potential infringement risks stem from similar formulations, chemical entities, or methods that fall within the patent claims, necessitating due diligence and freedom-to-operate analysis.
5. How can patent landscape analysis benefit commercialization?
It helps identify patent gaps, avoid infringement, strategize licensing or partnerships, and prioritize R&D investments.
References
- Rospatent Patent Database. (2012). Patent RU2010149050.
- European Patent Office. (2022). Global patent landscape reports.
- WIPO. (2023). Patent Cooperation Treaty status of pharmaceutical patents.
[Note: Specific internal claim details and prior art references should be obtained directly from the patent document for a thorough legal analysis.]
